No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 22, Issue 1, Pages 64-72
Publisher
SAGE Publications
Online
2015-10-03
DOI
10.1177/1352458515604383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
- (2015) Jaime Imitola et al. JAMA Neurology
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Subclinical MRI disease activity influences cognitive performance in MS patients
- (2015) Alfredo Damasceno et al. Multiple Sclerosis and Related Disorders
- Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations
- (2014) Mark S. Freedman et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Disease Activity Free Status
- (2014) Carolyn J. Bevan et al. JAMA Neurology
- Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies
- (2014) Kunio Nakamura et al. NeuroImage-Clinical
- Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model
- (2014) Martin Stangel et al. Therapeutic Advances in Neurological Disorders
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Measurement and clinical effect of grey matter pathology in multiple sclerosis
- (2012) Jeroen JG Geurts et al. LANCET NEUROLOGY
- Within-subject template estimation for unbiased longitudinal image analysis
- (2012) Martin Reuter et al. NEUROIMAGE
- Disease activity free status in MS
- (2011) Fred D. Lublin Multiple Sclerosis and Related Disorders
- Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline
- (2010) Sarah A. Morrow et al. CLINICAL NEUROPSYCHOLOGIST
- Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
- (2010) LVAE Bosma et al. Multiple Sclerosis Journal
- Reliability, practice effects, and change indices for Rao’s brief repeatable battery
- (2010) Emilio Portaccio et al. Multiple Sclerosis Journal
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- The prediction of Change: Normative neuropsychological trajectories
- (2008) Deborah K. Attix et al. CLINICAL NEUROPSYCHOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now